Evidence generation plan for digital platforms to support cardiac rehabilitation: early value assessment
5 Minimum evidence standards
During the period of evidence generation new technologies may become available. This section summarises the minimum evidence requirements that a new technology would need to meet to be considered in the NICE evaluation after the evidence generation period.
The committee heard that the digital platforms have comparable clinical effectiveness to conventional cardiac rehabilitation and that the technologies could increase access to cardiac rehabilitation in some populations. But the evidence for this is uncertain.
For new technologies, the committee has indicated that it may, in the future, be able to recommend technologies in this topic area that have UK-based evidence for:
-
non-inferiority of the digital platforms compared with conventional cardiac rehabilitation in terms of clinical effectiveness
-
user engagement with the technology, including intervention acceptance, usability and completion rates
-
cost savings resulting from resource use associated with the technologies.
Companies can strengthen the evidence base by also having evidence for uptake rates in different subpopulations.
This page was last updated: